Adlai Nortye Ltd
Officers & Directors
Yang Lu, age 47, serves as Chairman of the Board of Directors and Chief Executive Officer. He co-founded the group and has over 20 years of experience in the pharmaceutical industry, including prior work at Hybio Pharmaceutical Co., Ltd. He holds a bachelor's degree in biotechnology from Xiamen University and an EMBA from China Europe International Business School.
Ping Ji, age 62, is a Director with more than 25 years of experience in biopharmaceutical drug development. She has held global safety leadership positions at Kyowa Kirin Co., Ltd., Bayer HealthCare Pharmaceuticals Inc., Taiho, Bristol-Myers Squibb Company, Sanofi S.A., and Pfizer Corporation. She holds a Master of Medicine from Rutgers and UMDNJ and a Doctor of Medicine from Capital Institute of Medicine in the PRC.
Lars Erik Birgerson, age 74, is a Director with over 32 years of pharmaceutical industry experience. He previously served as president and CEO of Adlai Nortye USA Inc. and as the company's Chief Medical Officer. He has held senior medical affairs roles at Roche Pharmaceuticals, Genentech, and Bristol-Myers Squibb. He holds a Doctor of Medicine and PhD from Uppsala University and is a certified specialist in obstetrics and gynecology.
Roger Sawhney, age 57, is an Independent Director with nearly 30 years of financial and strategic experience in life sciences. He is currently Chief Financial Officer of LB Pharmaceuticals and has served as CFO of Garuda Therapeutics, Inc. and Omega Therapeutics, Inc., as well as Director of healthcare investment at KKR & Co. Inc.
Adlai Nortye Ltd currently has 123 employees.
|
